(Q40118862)

17 September 2017

1 reference

title

Aminoglutethimide in the treatment of advanced breast cancer (English)

1 reference

17 September 2017

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90008-2

4 September 2023

author name string

R. C. Stuart-Harris

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6241038

4 September 2023

I. E. Smith

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6241038

4 September 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6241038

4 September 2023

publication date

1 September 1984

1 reference

full work available at URL

17 September 2017

https://api.elsevier.com/content/article/PII:0305737284900082?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90008-2

https://api.elsevier.com/content/article/PII:0305737284900082?httpAccept=text/plain

4 September 2023

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90008-2

4 September 2023

published in

Cancer Treatment Reviews

1 reference

17 September 2017

11

1 reference

17 September 2017

189-204

1 reference

17 September 2017

3

1 reference

Biosynthesis of 17β-oestradiol in human breast carcinoma tissue and a novel method for its characterization

17 September 2017

1

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90008-2

Treatment of metastatic breast cancer with aminoglutethimide

4 September 2023

2

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90008-2

Pros and cons of aminoglutethimide for advanced postmenopausal breast cancer

4 September 2023

6

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90008-2

Aminoglutethimide (Elipten-Ciba) as an inhibitor of adrenal steroidogenesis: mechanism of action and therapeutic trial.

4 September 2023

8

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90008-2

Treatment of metastatic breast cancer with aminoglutethimide

4 September 2023

9

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90008-2

Tamoxifen and aminoglutethimide in advanced breast cancer

4 September 2023

10

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90008-2

A comparative evaluation of adrenalectomy and cortisone in the treatment of advanced mammary carcinoma

4 September 2023

12

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90008-2

Inhibition of adrenal corticosteroid synthesis by aminoglutethimide: studies of the mechanism of action.

4 September 2023

14

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90008-2

The management of metastatic breast cancer by hormone manipulation

4 September 2023

15

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90008-2

Effects of amino-glutethimide on adrenal function in man.

4 September 2023

16

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90008-2

Antitumor efficacy of prednisone and sodium liothyronine in advanced breast cancer

4 September 2023

19

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90008-2

Hormonal treatment of disseminated cancer of the female breast

4 September 2023

21

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90008-2

Modifiers of steroid-hormone metabolism: a review of their chemistry, biochemistry and clinical applications

4 September 2023

22

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90008-2

Stereoselective Inhibition of Aromatase by Enantiomers of Aminoglutethimide*

4 September 2023

23

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90008-2

Preliminary trial of aminoglutethimide in breast cancer

4 September 2023

24

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90008-2

Source of Estrogen Production in Postmenopausal Women1

4 September 2023

25

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90008-2

Treatment of metastatic breast cancer with aminoglutethimide

4 September 2023

26

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90008-2

Endocrine and Therapeutic Effects of Aminoglutethimide in Premenopausal Patients with Breast Cancer

4 September 2023

27

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90008-2

Aminoglutethimide in the treatment of advanced postmenopausal breast cancer

4 September 2023

28

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90008-2

Aminoglutethimide dose and hormone suppression in advanced breast cancer

4 September 2023

29

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90008-2

Endocrine effects of low dose aminoglutethimide alone in advanced postmenopausal breast cancer

4 September 2023

30

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90008-2

Hydrocortisone alone vs hydrocortisone plus aminogluthethimide: a comparison of the endocrine effects in postmenopausal breast cancer

4 September 2023

31

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90008-2

A comparative trial of transsphenoidal hypophysectomy and estrogen suppression with aminoglutethimide in advanced breast cancer

4 September 2023

32

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90008-2

Cross-over comparison of tamoxifen and aminoglutethimide in advanced breast cancer

4 September 2023

33

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90008-2

Medical adrenalectomy in patients with advanced breast cancer

4 September 2023

34

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90008-2

Aminoglutethimide: a "side-effect" turned to therapeutic advantage

4 September 2023

35

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90008-2

Steroid metabolism by human breast tumours

4 September 2023

39

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90008-2

Use of aminoglutethimide as second-line endocrine therapy in metastatic breast cancer

4 September 2023

41

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90008-2

The present status of hormone therapy in advanced breast cancer

4 September 2023

42

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90008-2

Experience with 6-aminoglutethimide in the treatment of metastatic breast cancer

4 September 2023

43

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90008-2

The use of prednisolone in the treatment of disseminated breast carcinoma

4 September 2023

44

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90008-2

Influence of estrogen receptor status on response of metastatic breast cancer to aminoglutethimide therapy

4 September 2023

45

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90008-2

Cortisone-thyroid therapy of metastatic mammary cancer.

4 September 2023

46

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90008-2

Prednisone therapy of advanced mammary cancer

4 September 2023

47

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90008-2

Proceedings: Medical adrenalectomy using aminoglutethimide and dexamethasone in advanced breast cancer.

4 September 2023

48

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90008-2

Randomized trial of aminoglutethimide versus tamoxifen in metastatic breast cancer

4 September 2023

49

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90008-2

Methods and results of aromatization studies in vivo

4 September 2023

50

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90008-2

Plasma Precursors of Estrogen. I. Extent of Conversion of Plasma Δ4-Androstenedione to Estrone in Normal Males and Nonpregnant Normal, Castrate and Adrenalectomized Females

4 September 2023

51

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90008-2

Aminoglutethimide and advanced breast cancer [proceedings]

4 September 2023

52

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90008-2

Oestradiol synthesis from C19 steroids by human breast cancers

4 September 2023

53

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90008-2

Serum Aminoglutethimide Levels: Studies of Serum Half-Life, Clearance, and Patient Compliance

4 September 2023

54

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90008-2

Aminoglutethimide in tamoxifen-resistant patients: The Melbourne Experience

4 September 2023

55

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90008-2

Phase II study of aminoglutethimide and medroxyprogesterone acetate in the treatment of patients with advanced breast cancer

4 September 2023

57

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90008-2

Medical and surgical adrenalectomy in patients with advanced breast carcinoma

4 September 2023

58

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90008-2

Medical adrenalectomy and plasma steroids in advanced breast carcinoma

4 September 2023

59

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90008-2

Cortisone treatment of metastatic breast cancer

4 September 2023

60

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90008-2

The use of hydrocortisone in cancer

4 September 2023

62

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90008-2

Androgen production and conversion to estrogens in normal postmenopausal women and in selected breast cancer patients

4 September 2023

63

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90008-2

Biochemistry of aromatase: significance to female reproductive physiology

4 September 2023

65

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90008-2

Adrenal suppression with aminoglutethimide. II. Differential effects of aminoglutethimide on plasma androstenedione and estrogen levels

4 September 2023

66

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90008-2

Adrenal Suppression with Aminoglutethimide. III. Comparison of Plasma Δ4- and Δ5-Steroids in Postmenopausal Women Treated for Breast Carcinoma*

4 September 2023

67

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90008-2

Potency of the effect of D-stereoisomer of aminoglutethimide on adrenal and extraadrenal steroidogenesis

4 September 2023

68

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90008-2

Preservation of androgen secretion during estrogen suppression with aminoglutethimide in the treatment of metastatic breast carcinoma

4 September 2023

69

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90008-2

Kinetic, hormonal and clinical studies with aminoglutethimide in breast cancer

4 September 2023

71

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90008-2

Aminoglutethimide Inhibits Extraglandular Estrogen Production in Postmenopausal Women with Breast Carcinoma*

4 September 2023

72

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90008-2

Resistance of the ovary to blockade of aromatization with aminoglutethimide

4 September 2023

73

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90008-2

Aminoglutethimide: review of pharmacology and clinical use.

4 September 2023

74

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90008-2

A randomized trial comparing surgical adrenalectomy with aminoglutethimide plus hydrocortisone in women with advanced breast cancer

4 September 2023

75

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90008-2

Aminoglutethimide as treatment of postmenopausal women with advanced breast carcinoma

4 September 2023

76

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90008-2

Conversion of androstenedione to estrone by human tissue.

4 September 2023

77

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90008-2

Aromatization of Androstenedione by Isolated Human Hairs

4 September 2023

78

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90008-2

Aromatization of androstenedione by cultured human fibroblasts

4 September 2023

79

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90008-2

Hormonal therapy in cancer of the breast. VI. Effect of ACTH and cortisone on clinical course and hormonal excretion

4 September 2023

80

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90008-2

Aminoglutethimide in treatment of metastatic breast carcinoma

4 September 2023

81

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90008-2

Tamoxifen versus aminoglutethimide in advanced breast carcinoma: a randomized cross-over trial

4 September 2023

82

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90008-2

Tamoxifen versus aminoglutethimide versus combined tamoxifen and aminoglutethimide in the treatment of advanced breast carcinoma

4 September 2023

83

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90008-2

Combination treatment with tamoxifen and aminoglutethimide in advanced breast cancer.

4 September 2023

84

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90008-2

Aromatization of androstenedione by human adult liver in vitro

4 September 2023

85

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90008-2

Dexamethasone in advanced breast cancer

4 September 2023

86

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90008-2

Corticosteroids in Therapy of Advanced Mammary Cancer.

4 September 2023

87

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90008-2

COMPARISON OF 6-ALPHA-METHYL-9-ALPHA-FLUORO-17-ACETOXY-21-DEOXYPREDNISOLONE WITH FLUOXYMESTERONE AND METHYLPREDNISOLONE IN TREATMENT OF METASTATIC BREAST CANCER

4 September 2023

88

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90008-2

Aminoglutethimide in the treatment of metastatic breast cancer

4 September 2023

89

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90008-2

Aminoglutethimide and glutethimide: effects on 18-hydroxycorticosterone biosynthesis by human and sheep adrenals in vitro

4 September 2023

90

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90008-2

Stereoselective inhibition of cholesterol side chain cleavage by enantiomers of aminoglutethimide

4 September 2023

91

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90008-2

Long-term treatment with corticosteroids of patients with metastatic breast cancer

4 September 2023

92

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90008-2

Effects of aminoglutethimide on adrenal steroid secretion

4 September 2023

94

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90008-2

Medical adrenalectomy with aminoglutethimide: clinical studies in postmenopausal patients with metastatic breast carcinoma

4 September 2023

97

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90008-2

4 September 2023

Identifiers

1 reference

17 September 2017

1 reference